Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2022 Filed May 25, 2022 16:11 UTC |
Buller Richard EDirector
|
SaleCommon Stock | 750 | $6.24 | $4,682.78 |
DisclosureSEC source: 0001437749-22-013539 · rdgdoc.xml · nonDerivative · entry 1 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,798 F1 · balance_after: Includes 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:41 UTC |
Buller Richard EDirector
|
SaleCommon Stock | 250 | $5.65 | $1,412.50 |
DisclosureSEC source: 0001437749-22-013319 · rdgdoc.xml · nonDerivative · entry 1 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,548 F1 · balance_after: Includes 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 29 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-05-17 F12 · derivative.exercise_date: These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 6,569 | Not disclosed Strike: $17.19 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 28 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 Underlying: Common Stock · 6,569 shares Expires 2031-10-27 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 1,642 shares vest on 10/27/22; the remaining 4,927 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 6,569 | Not disclosed Strike: $17.19 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 27 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,569 shares Expires 2031-10-27 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 1,642 shares vest on 10/27/22; the remaining 4,927 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 26 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-08-11 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $20.04 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 25 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2031-08-31 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 17,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 24 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-08-11 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 17,000 | Not disclosed Strike: $20.04 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 23 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,000 shares Expires 2031-08-11 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 13,509 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 22 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,509 Underlying: Common Stock · 13,509 shares Expires 2031-04-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 3,377 shares vest on 4/12/22; the remaining 10,132 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 13,509 | Not disclosed Strike: $27.94 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 21 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,509 shares Expires 2031-04-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 3,377 shares vest on 4/12/22; the remaining 10,132 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 11,889 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 20 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,889 Underlying: Common Stock · 11,889 shares Expires 2031-03-18 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 2,972 shares vest on 3/18/22; the remaining 8,917 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 11,889 | Not disclosed Strike: $15.92 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 19 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,889 shares Expires 2031-03-18 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 2,972 shares vest on 3/18/22; the remaining 8,917 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 12,859 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 18 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,859 Underlying: Common Stock · 12,859 shares Expires 2031-02-02 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 3,214 shares vest on 2/2/22; the remaining 9,645 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 12,859 | Not disclosed Strike: $14.84 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 17 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,859 shares Expires 2031-02-02 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 3,214 shares vest on 2/2/22; the remaining 9,645 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 11,081 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 16 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,081 Underlying: Common Stock · 11,081 shares Expires 2030-12-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F6 · derivative.exercise_date: 2,770 shares vest on 12/29/21; the remaining 8,311 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 11,081 | Not disclosed Strike: $10.35 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 15 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,081 shares Expires 2030-12-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F6 · derivative.exercise_date: 2,770 shares vest on 12/29/21; the remaining 8,311 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 4,985 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 12 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,985 Underlying: Common Stock · 4,985 shares Expires 2029-08-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,985 | Not disclosed Strike: $19.72 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 11 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,985 shares Expires 2029-08-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 10 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-08-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $19.72 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 9 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2029-08-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 14,675 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 8 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,675 Underlying: Common Stock · 14,675 shares Expires 2028-08-13 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 3,668 shares vest on 10/17/19; the remaining 11,007 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 14,675 | Not disclosed Strike: $25.77 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 7 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,675 shares Expires 2028-10-17 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 3,668 shares vest on 10/17/19; the remaining 11,007 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 3,769 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 6 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,769 Underlying: Common Stock · 3,769 shares Expires 2028-08-13 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,769 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 5 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,769 shares Expires 2028-08-13 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 8,220 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 4 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,220 Underlying: Common Stock · 8,220 shares Expires 2027-09-19 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:36 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 8,220 | Not disclosed Strike: $9.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013126 · rdgdoc.xml · derivative · entry 3 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,220 shares Expires 2027-09-19 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 38,412 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 22 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,412 Underlying: Common Stock · 38,412 shares Expires 2032-05-17 F12 · derivative.exercise_date: These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 1,877 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 21 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,877 Underlying: Common Stock · 1,877 shares Expires 2031-10-27 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,877 | Not disclosed Strike: $17.19 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 20 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,877 shares Expires 2031-10-27 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 19 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-08-11 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $20.04 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 18 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2031-08-11 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 6,754 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 17 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,754 Underlying: Common Stock · 6,754 shares Expires 2031-04-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 6,754 | Not disclosed Strike: $27.94 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 16 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,754 shares Expires 2031-04-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 2,973 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 15 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,973 Underlying: Common Stock · 2,973 shares Expires 2031-03-18 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,973 | Not disclosed Strike: $15.92 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 14 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,973 shares Expires 2031-03-18 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 3,215 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 13 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,215 Underlying: Common Stock · 3,215 shares Expires 2031-02-02 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,215 | Not disclosed Strike: $14.84 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 12 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,215 shares Expires 2031-02-02 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 2,771 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 11 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,771 Underlying: Common Stock · 2,771 shares Expires 2030-12-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F6 · derivative.exercise_date: 692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,771 | Not disclosed Strike: $10.35 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 10 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,771 shares Expires 2030-12-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F6 · derivative.exercise_date: 692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 8 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-08-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $19.72 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 7 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2029-08-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 1,834 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 6 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,834 Underlying: Common Stock · 1,834 shares Expires 2019-10-17 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 458 shares vest on 10/17/19; the remaining 1,376 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,834 | Not disclosed Strike: $25.77 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 5 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,834 shares Expires 2028-10-17 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 458 shares vest on 10/17/19; the remaining 1,376 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 4 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Common Stock · 4,110 shares Expires 2027-09-19 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:37 UTC |
Laing Lance G.Director · Chief Science Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $9.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013127 · rdgdoc.xml · derivative · entry 3 Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,110 shares Expires 2027-09-19 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
Buller Richard EDirector
|
GrantStock Option (right to buy) · Derivative | 19,558 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013129 · rdgdoc.xml · derivative · entry 7 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,558 Underlying: Common Stock · 19,558 shares Expires 2032-05-17 F3 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
Buller Richard EDirector
|
GrantStock Option (right to buy) · Derivative | 2,310 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013129 · rdgdoc.xml · derivative · entry 5 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F4 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
Buller Richard EDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,310 | Not disclosed Strike: $26.99 | Not disclosed |
DisclosureSEC source: 0001437749-22-013129 · rdgdoc.xml · derivative · entry 4 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F4 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
Buller Richard EDirector
|
GrantStock Option (right to buy) · Derivative | 4,555 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013129 · rdgdoc.xml · derivative · entry 3 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,555 Underlying: Common Stock · 4,555 shares Expires 2029-12-03 F4 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.